fda ends semaglutide shortage Novo's Wegovy and Ozempic removed from US list, compounders on notice fda semaglutide shortage status january

1 However, despite this surge in interest and the compelling narrative equating it with Ozempic, the central scientific question remains: Is there clinical and molecular evidence that justifies the comparison of Berberine to semaglutide

While many people will respond to Wegovy and Ozempic for weight loss, up to about 15% of people will not respond to the drugs

CVS Caremark selected Wegovy as its preferred GLP-1 for weight loss effective July 1, 2025, removing Zepbound from these formulary types: [2] Standard Control Formulary Most common employer formulary Advanced Control Formulary More restrictive formulary with lower premiums Value Formulary Cost-focused formulary used by smaller employers Background: The Zepbound Class Action Lawsuits In September 2025, two class action lawsuits were filed by Zepbound patients against CVS Caremark: [3][8] (Sept

See the Switch & Save offer Frequently Asked Questions Is there an official Mounjaro to Wegovy dose conversion chart